..., the lower the ERI. The concept of ERI was first proposed by Gunnell et al. [ 4 ]. Before then, most studies about renal anemia were focused on the impact of Hgb on patients’ prognosis; it was later found that both low Hgb level and high EPO dose were strongly associated with an increased risk...

... was increased in CD14 ++ /CD16 + (60.8 ± 10%) than in CD14 ++ /CD16 - (15.5 ± 2%). Conclusions: Sera pools from CKD patients increase eryptosis and promote a proinflammatory monocyte phenotype. Both processes increased erythrophagocytosis, thereby suggesting a novel pathway for renal anemia. andrea.moreno...

... the lower limit, the dose was one-step increased. After study initiation, the criteria for the initiation of iron preparation administration were set at 20% or lower TAST with a 100-ng/ml or lower serum ferritin level, following the 2008 ‘Guidelines for treatment of renal anemia in chronic hemodialysis...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Renal anemia Low aluminum dialysate...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Renal anemia Hemodialysis Erythropoietin, intravenous Erythropoietin...

... Laboratory, Heidelberg; dFraunhofer Institute, Stuttgart, FRG Key Words. Renal anemia Recombinant human erythropoietin End-stage renal disease Aluminum overload Parathyroid hormone Abstract. In a European multicenter trial the weekly rates of increase in hematocrit and reticulocyte values were...

...Han Li; Shi-xiang Wang Background/Aims: Renal anemia is one of the commonest complications of chronic renal failure. Iron deficiency is the most common factor which affects the efficacy of recombinant human erythropoietin (EPO) therapy. Intravenous (i.v.) iron preparations are commonly used...

... Division and Institute of Nephrology, Peking University First Hospital, Beijing, and b Renal Division, Central Hospital of Mianyang, Mianyang, China Key Words Continuous quality improvement Renal anemia Hemodialysis Abstract Background: Anemia is common in hemodialysis patients, and improvement...

...Yoshihiro Matsumoto; Izumi Amano; Shinichi Hirose; Yoshinari Tsuruta; Shigeko Hara; Michio Murata; Tsuneki Imai While renal anemia can be successfully treated by use of erythropoietin (EPO) in most hemodialysis (HD) patients, some patients have anemia that is refractory to treatment with a high...

... discussed. The aim of the study was to assess the effects of therapy rHuEPO on cardiac morphology and function in dialysis patients. We studied 11 clinically stable hemodialysis patients with severe renal anemia (hematocrit <27%) and increased left ventricular mass index (LVMi) with no history...